| Product Image |
Product Name |
Product Description |
Company Name |
| |
F647
|
F647 is another anti-inflammatory small molecule compound designed to combat acute lung injury (ALT). SARS virus infection and lung cancer radiation therapy both cause acute lung injury, and in many cases, ... |
Shanghai Genomics,Inc. |
| |
F351
|
The small molecule compound F351 (NCE), developed by the Company as a non-steroid anti-fibrosis drug, has shown strong efficacy for treating a broad range of fibrosis diseases, especially in liver. Liver ... |
Shanghai Genomics,Inc. |
| |
Recombinant Human Interferon α -2b
|
Kawin's first major product is KAFERON —a product of Recombinant Human Interferon α -2b.
It is the first choice authorized by American FDA for the treatment of chronic hepatitis B and C caused by virus, ... |
Beijing Kawin Bio-Tech Co., Ltd |
| |
Vaccines and Biotherapeutics
|
The Center for Vaccines and Biotherapeutics aims to discover breakthrough biological products for preventing and treating human diseases.Working together with other scientists within the institute and ... |
Guangzhou Institute of Biomedicine and Health Chinese Academy of Sciences |
| |
Ganciclovir for Injection
|
Ganciclovir for Injection is one of the most broad-spectrum dugs anti-NDA viruses. |
Beijing Kawin Bio-Tech Co., Ltd |
| |
Diammonium Glycyrrhizinate Injection
|
properties:The third generation of glycyrrhizinate injection. Have intense effects on anti-inflammation, protecting hepatocyte membrane and improving liver function.
indication:Used for acute or chronic ... |
Beijing Kawin Bio-Tech Co., Ltd |